Your browser doesn't support javascript.
loading
Expanding buprenorphine treatment to people experiencing homelessness through a mobile, multidisciplinary program in an urban, underserved setting.
O'Gurek, David T; Jatres, Jillian; Gibbs, Jonetta; Latham, Ian; Udegbe, Byron; Reeves, Kathleen.
Afiliação
  • O'Gurek DT; Department of Family & Community Medicine, Lewis Katz School of Medicine at Temple University, 1316 W Ontario St, Philadelphia, PA 19140, United States of America; Center for Urban Bioethics, Lewis Katz School of Medicine at Temple University, 3200 N Broad St, Philadelphia, PA 19140, United Stat
  • Jatres J; Center for Urban Bioethics, Lewis Katz School of Medicine at Temple University, 3200 N Broad St, Philadelphia, PA 19140, United States of America.
  • Gibbs J; Center for Urban Bioethics, Lewis Katz School of Medicine at Temple University, 3200 N Broad St, Philadelphia, PA 19140, United States of America.
  • Latham I; Center for Urban Bioethics, Lewis Katz School of Medicine at Temple University, 3200 N Broad St, Philadelphia, PA 19140, United States of America.
  • Udegbe B; Center for Urban Bioethics, Lewis Katz School of Medicine at Temple University, 3200 N Broad St, Philadelphia, PA 19140, United States of America.
  • Reeves K; Center for Urban Bioethics, Lewis Katz School of Medicine at Temple University, 3200 N Broad St, Philadelphia, PA 19140, United States of America.
J Subst Abuse Treat ; 127: 108342, 2021 08.
Article em En | MEDLINE | ID: mdl-34134882
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Inequities in access to buprenorphine treatment remain despite measures to increase access to treatment. "Begin the Turn," a low-barrier, multidisciplinary mobile care unit with access to outreach services, counseling, case management, and buprenorphine treatment addresses these disparities in an urban setting.

METHODS:

Retrospective medical record review of patients during the initial 6 months of operation abstracted patient demographics and clinical data, including 10 categories of adverse childhood experiences (ACEs) using a total number of ACEs (ACE score) and measuring scores greater than or equal to 4 given higher risk of chronic disease states at this level. The study collected data in electronic data capture tools. The study assessed retention rates at 1, 3, and 5 months.

RESULTS:

Among the 147 individuals who received care, the mean age was 39.6 years and median onset of opioid use was 21 years of age. Among study participants, 67.3% (n = 99) reported IV use, 91.9% (n = 135) reported previous experiences with addiction treatment, and 49.7% (n = 73) had previously suffered an overdose. Adverse Childhood Experiences surveys demonstrated a mean score of 4.6 (n = 141), with 63.1% (n = 89) having a score of 4 or greater. The percentages of patients retained in care at 1, 3, and 5 months were 61.2%, 36.6%, and 27.6%, respectively. CONCLUSION AND SCIENTIFIC

SIGNIFICANCE:

The program serves a population with high rates of trauma and overdose. The program can serve as a model for treatment for this population.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoas Mal Alojadas / Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoas Mal Alojadas / Buprenorfina / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article